Michael Bestawros1, Dawood Darbar1, Amir Arain1, Bassel Abou-Khalil1, Dale Plummer1, William D Dupont1, Satish R Raj2. 1. From the Autonomic Dysfunction Center (M.B., W.D.D., S.R.R.), Departments of Medicine (M.B., D.D., S.R.R.), Pharmacology (D.D., S.R.R.), Neurology (A.A., B.A.-K.), and Biostatistics (D.P., W.D.D.), Vanderbilt University School of Medicine, Nashville, TN; Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada (S.R.R.). 2. From the Autonomic Dysfunction Center (M.B., W.D.D., S.R.R.), Departments of Medicine (M.B., D.D., S.R.R.), Pharmacology (D.D., S.R.R.), Neurology (A.A., B.A.-K.), and Biostatistics (D.P., W.D.D.), Vanderbilt University School of Medicine, Nashville, TN; Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada (S.R.R.). satish.raj@ucalgary.ca.
Abstract
BACKGROUND: Ictal asystole is a rare, serious, and often treatable cause of syncope. There are currently limited data to guide management. Characterization of ictal syncope predictors may aid in the selection of high-risk patients for treatments such as pacemakers. METHODS AND RESULTS: We searched our epilepsy monitoring unit database from October 2003 to July 2013 for all patients with ictal asystole events. Clinical, electroencephalogram, and ECG data for each of their seizures were examined for their relationships with ictal syncope events. In 10 patients with ictal asystole, we observed 76 clinical seizures with 26 ictal asystole episodes, 15 of which led to syncope. No seizure with asystole duration≤6 s led to syncope, whereas 94% (15/16) of seizures with asystole duration>6 s led to syncope (P=0.02). During ictal asystole events, 4 patients had left temporal seizure onset, 4 patients had right temporal seizure onset, and 2 patients had both. Syncope was more common with left temporal (40%) than with right temporal seizures (10%; P=0.002). Treatment options included antiepileptic drug changes, epilepsy surgery, and pacemaker implantation. Eight patients received pacemakers. During follow-up of 72±95 months, all patients remained syncope free. CONCLUSIONS: Ictal asystole>6 s is strongly associated with ictal syncope. Ictal syncope is more common in left than in right temporal seizures. A permanent pacemaker should be considered in patients with ictal syncope if they are not considered good candidates for epilepsy surgery.
BACKGROUND:Ictal asystole is a rare, serious, and often treatable cause of syncope. There are currently limited data to guide management. Characterization of ictal syncope predictors may aid in the selection of high-risk patients for treatments such as pacemakers. METHODS AND RESULTS: We searched our epilepsy monitoring unit database from October 2003 to July 2013 for all patients with ictal asystole events. Clinical, electroencephalogram, and ECG data for each of their seizures were examined for their relationships with ictal syncope events. In 10 patients with ictal asystole, we observed 76 clinical seizures with 26 ictal asystole episodes, 15 of which led to syncope. No seizure with asystole duration≤6 s led to syncope, whereas 94% (15/16) of seizures with asystole duration>6 s led to syncope (P=0.02). During ictal asystole events, 4 patients had left temporal seizure onset, 4 patients had right temporal seizure onset, and 2 patients had both. Syncope was more common with left temporal (40%) than with right temporal seizures (10%; P=0.002). Treatment options included antiepileptic drug changes, epilepsy surgery, and pacemaker implantation. Eight patients received pacemakers. During follow-up of 72±95 months, all patients remained syncope free. CONCLUSIONS:Ictal asystole>6 s is strongly associated with ictal syncope. Ictal syncope is more common in left than in right temporal seizures. A permanent pacemaker should be considered in patients with ictal syncope if they are not considered good candidates for epilepsy surgery.
Authors: Adam Strzelczyk; Margarethe Cenusa; Sebastian Bauer; Hajo M Hamer; Ian W Mothersill; Thomas Grunwald; Barbara Hillenbrand; Alois Ebner; Bernhard J Steinhoff; Günter Krämer; Felix Rosenow Journal: Epilepsia Date: 2011-02-14 Impact factor: 5.864
Authors: S U Schuele; A C Bermeo; A V Alexopoulos; E R Locatelli; R C Burgess; D S Dinner; N Foldvary-Schaefer Journal: Neurology Date: 2007-07-31 Impact factor: 9.910
Authors: Gena R Ghearing; Thomas M Munger; Allan S Jaffe; Eduardo E Benarroch; Jeffrey W Britton Journal: Clin Auton Res Date: 2007-07-16 Impact factor: 4.435
Authors: Fergus J Rugg-Gunn; Robert J Simister; Mark Squirrell; Diana R Holdright; John S Duncan Journal: Lancet Date: 2004 Dec 18-31 Impact factor: 79.321
Authors: Christoph Baumgartner; Johannes Koren; Martha Britto-Arias; Simone Schmidt; Susanne Pirker Journal: Clin Auton Res Date: 2019-02-25 Impact factor: 4.435
Authors: Stephanie Ballendine; Izn Shahab; Mitzel Perez-Careta; Francisco J Taveras-Almonte; Iris E Martínez-Juárez; Laura E Hernández-Vanegas; Chelsea Dolinsky; Adam Wu; Jose Francisco Tellez-Zenteno Journal: Epilepsy Behav Rep Date: 2019-07-30
Authors: Maully J Shah; Michael J Silka; Jennifer N Avari Silva; Seshadri Balaji; Cheyenne M Beach; Monica N Benjamin; Charles I Berul; Bryan Cannon; Frank Cecchin; Mitchell I Cohen; Aarti S Dalal; Brynn E Dechert; Anne Foster; Roman Gebauer; M Cecilia Gonzalez Corcia; Prince J Kannankeril; Peter P Karpawich; Jeffery J Kim; Mani Ram Krishna; Peter Kubuš; Martin J LaPage; Douglas Y Mah; Lindsey Malloy-Walton; Aya Miyazaki; Kara S Motonaga; Mary C Niu; Melissa Olen; Thomas Paul; Eric Rosenthal; Elizabeth V Saarel; Massimo Stefano Silvetti; Elizabeth A Stephenson; Reina B Tan; John Triedman; Nicholas H Von Bergen; Philip L Wackel Journal: Indian Pacing Electrophysiol J Date: 2021-07-29